Summary & Overview
CPT 80333: Multi‑Analyte Serotonergic Antidepressant Assay (3–5 Drugs)
CPT code 80333 identifies a laboratory assay that measures or detects three to five serotonergic antidepressant medications in a patient specimen. As a targeted toxicology test for psychiatric medications, this code matters nationally because it supports medication management, adherence assessment, and safety monitoring for patients on serotonergic agents. It is relevant to clinicians, laboratories, payers, and pharmacy management programs that oversee antidepressant therapy and potential drug interactions.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for use of the test, typical sites where the service is performed, and the kinds of benchmarks and policy considerations that commonly affect coding and coverage decisions for laboratory toxicology assays. The publication highlights common modifiers and practical billing metadata, explains typical clinical scenarios for ordering the test, and summarizes what payers generally evaluate when adjudicating claims for multi-analyte antidepressant testing.
What readers will learn: a clear definition of CPT code 80333, the clinical role of multi-analyte serotonergic antidepressant testing, payer landscape in national terms, and where to find further policy and billing guidance. Data not available in the input will be noted where applicable.
Billing Code Overview
CPT code 80333 describes a laboratory test in which the analyst measures the amount of, or detects the presence of, three to five serotonergic antidepressant medications in a patient specimen. This service is a targeted toxicology/drug assay focused on psychiatric medications that act on serotonin pathways.
-
Service type: Quantitative or qualitative multi-analyte drug assay for serotonergic antidepressants
-
Typical site of service: Clinical laboratory or hospital laboratory performing diagnostic toxicology testing
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 35-year-old outpatient with major depressive disorder managed on serotonergic agents presents for medication management after recent symptom changes and suspected nonadherence. The clinician orders therapeutic drug monitoring to measure serum concentrations of multiple serotonergic antidepressants to assess adherence, drug interactions, or unexpected levels. A phlebotomy technician collects a blood specimen at the outpatient laboratory or hospital outpatient service; the specimen is sent to the clinical laboratory. A laboratory analyst performs qualitative and quantitative testing that detects and/or measures three to five serotonergic antidepressant medications (for example, multiple selective serotonin reuptake inhibitors or serotonin–norepinephrine reuptake inhibitors) using methods such as liquid chromatography–mass spectrometry. Results are reported to the ordering psychiatrist, primary care provider, or pharmacy team. Typical sites of service include hospital outpatient laboratories, independent clinical reference laboratories, and ambulatory clinic laboratories. The clinical workflow includes order entry, specimen collection, chain-of-custody handling when required, laboratory analysis, result verification by a licensed laboratorian, and electronic results delivery to the ordering provider for clinical interpretation and follow-up.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default, no modifier | Used when no special circumstances apply and no other modifier is appropriate. |